Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: A United Kingdom multicentre retrospective experience

British Journal of Haematology

Volumn 157, Issue 3, 2012, Pages 339-346

  Samarasinghe, Sujith ^a   Steward, Colin ^b   Hiwarkar, Prashant ^c   Saif, Muhammad Ameer ^d   Hough, Rachael ^e   Webb, David ^c   Norton, Alice ^f   Lawson, Sarah ^f   Qureshi, Amrana ^g   Connor, Philip ^h   Carey, Peter ^a   Skinner, Rod ^a   Vora, Ajay ⁱ   Pelidis, Maria ^j   Gibson, Brenda ^k   Stewart, Graham ^k   Keogh, Steve ^c   Goulden, Nick ^c   Bonney, Denise ^d   Stubbs, Mathew ^d   Amrolia, Persis ^c   Rao, Kanchan ^c   Meyer, Stefan ^d   Wynn, Rob ^d   Veys, Paul ^c   more..

^a Infectious Diseases Allergy   (United Kingdom)

^b Royal Hospital for Children   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^f BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

ⁱ SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^j ST GEORGE S HOSPITAL   (United Kingdom)

^k ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

more..

Author keywords

Aplastic Anaemia; Immunosuppressive therapy; Paediatric aplastic anaemia; Rabbit ATG; Transplantation

Indexed keywords

ALEMTUZUMAB; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ADENOVIRUS INFECTION; ADOLESCENT; APLASTIC ANEMIA; ARTICLE; CHILD; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT FAILURE; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM; UNRELATED DONORS;

ADOLESCENT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; OPPORTUNISTIC INFECTIONS; RECURRENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TREATMENT FAILURE; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84859517537     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09066.x     Document Type: Article

References (40)

1. Ades, L., Mary, J.Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E. & Socie, G. (2004) Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood, 103, 2490-2497.
2. Afable, 2nd, M.G., Shaik, M., Sugimoto, Y., Elson, P., Clemente, M., Makishima, H., Sekeres, M.A., Lichtin, A., Advani, A., Kalaycio, M., Tiu, R.V., O'Keefe, C.L. & Maciejewski, J.P. (2011) Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica, 96, 1269-1275.
3. Alter, B.P., Giri, N., Savage, S.A. & Rosenberg, P.S. (2009) Cancer in dyskeratosis congenita. Blood, 113, 6549-6557.
4. Atta, E.H., Dias, D.S., Marra, V.L. & de Azevedo, A.M. (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Annals of Hematology, 89, 851-859.
5. Azuma, E., Kojima, S., Kato, K., Matsuyama, T., Yamada, Y., Kondo, N., Sawada, H., Hanada, M., Shibata, T., Tabata, N., Watanabe, M., Shimono, Y., Deguchi, T., Umemoto, M., Higashikawa, M., Kawasaki, H., Komada, Y. & Sakurai, M. (1997) Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Bone Marrow Transplantation, 19, 1085-1087.
6. Bacigalupo, A., Socie, G., Lanino, E., Prete, A., Locatelli, F., Locasciulli, A., Cesaro, S., Shimoni, A., Marsh, J., Brune, M., Van Lint, M.T., Oneto, R. & Passweg, J. (2010) Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica, 95, 976-982.
7. Calado, R.T. & Young, N.S. (2008) Telomere maintenance and human bone marrow failure. Blood, 111, 4446-4455.
8. Camitta, B.M. (2000) What is the definition of cure for aplastic anemia? Acta Haematologica, 103, 16-18.
9. Deeg, H.J., Socie, G., Schoch, G., Henry-Amar, M., Witherspoon, R.P., Devergie, A., Sullivan, K.M., Gluckman, E. & Storb, R. (1996) Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood, 87, 386-392.
10. Deeg, H.J., O'Donnell, M., Tolar, J., Agarwal, R., Harris, R.E., Feig, S.A., Territo, M.C., Collins, R.H., McSweeney, P.A., Copelan, E.A., Khan, S.P., Woolfrey, A. & Storer, B. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood, 108, 1485-1491.
11. Fogarty, P.F., Yamaguchi, H., Wiestner, A., Baerlocher, G.M., Sloand, E., Zeng, W.S., Read, E.J., Lansdorp, P.M. & Young, N.S. (2003) Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet, 362, 1628-1630.
12. Fuhrer, M., Burdach, S., Ebell, W., Gadner, H., Haas, R., Harbott, J., Janka-Schaub, G., Klingebiel, T., Kremens, B., Niemeyer, C., Rampf, U., Reiter, A., Ritter, J., Schulz, A., Walther, U., Zeidler, C. & Bender-Gotze, C. (1998) Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klinische Padiatrie, 210, 173-179.
13. Fuhrer, M., Rampf, U., Baumann, I., Faldum, A., Niemeyer, C., Janka-Schaub, G., Friedrich, W., Ebell, W., Borkhardt, A. & Bender-Goetze, C. (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood, 106, 2102-2104.
14. Garg, R., Faderl, S., Garcia-Manero, G., Cortes, J., Koller, C., Huang, X., York, S., Pierce, S., Brandt, M., Beran, M., Borthakur, G., Kantarjian, H. & Ravandi, F. (2009) Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia, 23, 1297-1302.
15. Gupta, V., Ball, S.E., Sage, D., Ortin, M., Freires, M., Gordon-Smith, E.C. & Marsh, J.C. (2005) Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplantation, 35, 467-471.
16. Kamio, T., Ito, E., Ohara, A., Kosaka, Y., Tsuchida, M., Yagasaki, H., Mugishima, H., Yabe, H., Morimoto, A., Ohga, S., Muramatsu, H., Hama, A., Kaneko, T., Nagasawa, M., Kikuta, A., Osugi, Y., Bessho, F., Nakahata, T., Tsukimoto, I. & Kojima, S. (2011) Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group. Haematologica, 96, 814-819.
17. Kennedy-Nasser, A.A., Leung, K.S., Mahajan, A., Weiss, H.L., Arce, J.A., Gottschalk, S., Carrum, G., Khan, S.P., Heslop, H.E., Brenner, M.K., Bollard, C.M. & Krance, R.A. (2006) Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant, 12, 1277-1284.
18. Klangsinsirikul, P., Carter, G.I., Byrne, J.L., Hale, G. & Russell, N.H. (2002) Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood, 99, 2586-2591.
19. Kojima, S., Matsuyama, T., Kato, S., Kigasawa, H., Kobayashi, R., Kikuta, A., Sakamaki, H., Ikuta, K., Tsuchida, M., Hoshi, Y., Morishima, Y. & Kodera, Y. (2002a) Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood, 100, 799-803.
20. Kojima, S., Ohara, A., Tsuchida, M., Kudoh, T., Hanada, R., Okimoto, Y., Kaneko, T., Takano, T., Ikuta, K. & Tsukimoto, I. (2002b) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood, 100, 786-790.
21. Kosaka, Y., Yagasaki, H., Sano, K., Kobayashi, R., Ayukawa, H., Kaneko, T., Yabe, H., Tsuchida, M., Mugishima, H., Ohara, A., Morimoto, A., Otsuka, Y., Ohga, S., Bessho, F., Nakahata, T., Tsukimoto, I. & Kojima, S. (2008) Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood, 111, 1054-1059.
22. Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J. & Fuhrer, M. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 92, 11-18.
23. Marsh, J.C., Ball, S.E., Cavenagh, J., Darbyshire, P., Dokal, I., Gordon-Smith, E.C., Keidan, J., Laurie, A., Martin, A., Mercieca, J., Killick, S.B., Stewart, R. & Yin, J.A. (2009) Guidelines for the diagnosis and management of aplastic anaemia. British Journal of Haematology, 147, 43-70.
24. Marsh, J.C., Gupta, V., Lim, Z., Ho, A.Y., Ireland, R.M., Hayden, J., Potter, V., Koh, M.B., Islam, M.S., Russell, N., Marks, D.I., Mufti, G.J. & Pagliuca, A. (2011) Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood, 118, 2351-2357.
25. Maury, S., Balere-Appert, M.L., Chir, Z., Boiron, J.M., Galambrun, C., Yakouben, K., Bordigoni, P., Marie-Cardine, A., Milpied, N., Kanold, J., Maillard, N. & Socie, G. (2007) Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica, 92, 589-596.
26. Passweg, J.R., Perez, W.S., Eapen, M., Camitta, B.M., Gluckman, E., Hinterberger, W., Hows, J.M., Marsh, J.C., Pasquini, R., Schrezenmeier, H., Socie, G., Zhang, M.J. & Bredeson, C. (2006) Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplantation, 37, 641-649.
27. Perez-Albuerne, E.D., Eapen, M., Klein, J., Gross, T.J., Lipton, J.M., Baker, K.S., Woolfrey, A. & Kamani, N. (2008) Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. British Journal of Haematology, 141, 216-223.
28. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825-828.
29. Rao, K., Amrolia, P.J., Jones, A., Cale, C.M., Naik, P., King, D., Davies, G.E., Gaspar, H.B. & Veys, P.A. (2005) Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood, 105, 879-885.
30. Ratzinger, G., Reagan, J.L., Heller, G., Busam, K.J. & Young, J.W. (2003) Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation. Blood, 101, 1422-1429.
31. Rizzo, J.D., Curtis, R.E., Socie, G., Sobocinski, K.A., Gilbert, E., Landgren, O., Travis, L.B., Travis, W.D., Flowers, M.E., Friedman, D.L., Horowitz, M.M., Wingard, J.R. & Deeg, H.J. (2009) Solid cancers after allogeneic hematopoietic cell transplantation. Blood, 113, 1175-1183.
32. Sanders, J.E., Woolfrey, A.E., Carpenter, P.A., Storer, B.E., Hoffmeister, P.A., Deeg, H.J., Flowers, M.E. & Storb, R.F. (2011) Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood, 118, 1421-1428.
33. Scheinberg, P., Wu, C.O., Nunez, O. & Young, N.S. (2008) Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. Journal of Pediatrics, 153, 814-819.
34. Scheinberg, P., Nunez, O., Weinstein, B., Biancotto, A., Wu, C.O. & Young, N.S. (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. New England Journal of Medicine, 365, 430-438.
35. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. & Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204-217.
36. Siegal, D., Xu, W., Sutherland, R., Kamel-Reid, S., Kuruvilla, J., Lipton, J.H., Minden, M., Messner, H. & Gupta, V. (2008) Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplantation, 42, 51-56.
37. Vassiliou, G.S., Webb, D.K., Pamphilon, D., Knapper, S. & Veys, P.A. (2001) Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. British Journal of Haematology, 114, 701-705.
38. Viollier, R., Socie, G., Tichelli, A., Bacigalupo, A., Korthof, E.T., Marsh, J., Cornish, J., Ljungman, P., Oneto, R., Bekassy, A.N., Fuehrer, M., Maury, S., Schrezenmeier, H., van Lint, M.T., Wojcik, D., Locasciulli, A. & Passweg, J.R. (2008) Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplantation, 41, 45-50.
39. Young, N.S., Calado, R.T. & Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 2509-2519.
40. Zheng, Y., Liu, Y. & Chu, Y. (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Experimental Hematology, 34, 826-831.